ERAXIS 50 mg/15mL

ERAXIS 50 mg/15mL is a lyophilized powder for injection containing anidulafungin. It is used for treating fungal infections, including invasive candidiasis. This intravenous medication is designed for single-use administration.

ERAXIS 50 mg/15mL is primarily used for the treatment of fungal infections, such as invasive candidiasis. It is an antifungal medication that works by targeting the fungal cell wall, helping to combat the infection. This medication is often prescribed when other treatments are not suitable or effective. What is ERAXIS used for? It is used for managing serious fungal infections in patients who require intravenous antifungal therapy.

Common effects of ERAXIS 50 mg/15mL may include infusion-related reactions, such as fever, chills, or rash. Some patients may experience gastrointestinal issues like nausea or diarrhea. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

ERAXIS 50 mg/15mL should be handled with care, ensuring proper reconstitution and administration procedures are followed. It is important to inform healthcare providers of any allergies or pre-existing conditions before use. This medication is for intravenous use only and should be administered by a healthcare professional.

ERAXIS 50 mg/15mL may interact with certain medications, including those metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect liver function should be avoided during treatment.